The FDA has given clearance to NDS Surgical Imaging for the Dome S6c diagnostic display.
The U.S. Food and Drug Administration has given 510(k) clearance for the Dome S6c display, a 6-megapixel LED widescreen diagnostic display.
The Dome S6c’s 30-inch widescreen can be viewed as a single 6 megapixel (MP) format, or in a dual 3 MP bezel-free arrangement. The display provides both grayscale and color images. With a native resolution of 3280 × 2048, the display is optimized for viewing a variety of modalities, including CR, DR, MR, CT, PET-CT, ultrasound, and 3D volume rendering. The 800cd/m2 high-bright LED-backlight technology and 1000:1 contrast ratio offers unique optical clarity and image brightness in varying light environments.
[[{"type":"media","view_mode":"media_crop","fid":"23553","attributes":{"alt":"","class":"media-image media-image-right","height":"201","id":"media_crop_3914253316857","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1886","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"border-width: 0px; border-style: solid; margin: 1px; float: right;","title":" ","typeof":"foaf:Image","width":"247"}}]]
“Hallmarks of Dome’s intelligent engineering such as factory calibration, fanless cooling, non-reflective screens and ultra-slim design set the new Dome S6c apart as the most advanced, forward-thinking 6MP display available today,” Bill Carrano, president and general manager of NDSsi, the manufacturer of the Dome S6c display, said in a release.
The display weighs in at 29 lbs, making it easily maneuverable, and offers low-power LED performance. The display boasts a 170° viewing angle and is in DICOM compliance with no further field calibration required. Dome S6c includes a front sensor that performs daily DICOM conformance testing automatically, and on demand as needed.
The Dome S6c is the latest addition to the NDSsi S-series product family.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.